Free equity investment tool of Japanese companies

Credit Rating (Bankruptcy Risk): AIN PHARMACIEZ (Annual ) Consolidated | Non-Consolidated

Financial Timeline

Financial Statement Risk Analysis: AIN PHARMACIEZ (Annual ) (Consolidated )

Special note

Net sales and net income has increased 5 consecutive terms, and, because of positive operating cash flow. The performance is good.

Net Assets have increased 5consecutive terms. The fiscal base is getting better.

[Date: 2013-04-30]  Danger : Warning : Caution : Good

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (3.28％) is first term Net Profit Margin (3.43％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ 5 B) & Operating Cash Flow (¥ 10 B) , Dividend (¥ -797 M) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 154 B) is first term (¥ 142 B) more, however Operating Cash Flow (¥ 10 B) is first term (¥ 11 B) less , there is a possibility that the financing has deteriorated very much.

[Date: 2012-04-30]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -9 B) & Financial Cash Flow (¥ -2 B) is a minus, Operating Cash Flow (¥ 11 B) is a plus,

Dividend
Under the situation of Net Income (¥ 4 B) & Operating Cash Flow (¥ 11 B) , Dividend (¥ -717 M) is paid.

[Date: 2011-04-30]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 3 B) & Operating Cash Flow (¥ 7 B) , Dividend (¥ -564 M) is paid.

[Date: 2010-04-30]  Danger : Warning : Caution : Good

Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -1 B) is a minus, Issuance of new shares (¥ 2 B) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -2 B) & Financial Cash Flow (¥ -1 B) is a minus, Operating Cash Flow (¥ 6 B) is a plus,

Dividend
Under the situation of Net Income (¥ 3 B) & Operating Cash Flow (¥ 6 B) , Dividend (¥ -384 M) is paid.

[Date: 2009-04-30]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 2 B) & Operating Cash Flow (¥ 4 B) , Dividend (¥ -207 M) is paid.

Credit Rating (Bankruptcy Risk): AIN PHARMACIEZ (Annual ) Consolidated | Non-Consolidated

Financial Timeline

Financial Statement Risk Analysis: AIN PHARMACIEZ (Annual ) (Non-Consolidated )

[Date: 2011-04-30]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (-) , Dividend (¥ -564 M) is paid.

[Date: 2010-04-30]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 965 M) & Operating Cash Flow (-) , Dividend (¥ -384 M) is paid.

[Date: 2009-04-30]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 620 M) & Operating Cash Flow (-) , Dividend (¥ -227 M) is paid.